Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

Daniele Pastori; Gregory Y.H. Lip; Alessio Farcomeni; Francesco Del Sole; Angela Sciacqua; Francesco Perticone; Rossella Marcucci; Elisa Grifoni; Pasquale Pignatelli; Francesco Violi

Data in Brief (Apr 2018)

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

Daniele Pastori,
Gregory Y.H. Lip,
Alessio Farcomeni,
Francesco Del Sole,
Angela Sciacqua,
Francesco Perticone,
Rossella Marcucci,
Elisa Grifoni,
Pasquale Pignatelli,
Francesco Violi

Affiliations

Daniele Pastori: I Clinica Medica, Atherothrombosis Centre, Department of Internal Medicine and Medical Specialties of Sapienza University of Rome, Rome, Italy; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom
Gregory Y.H. Lip: Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom
Alessio Farcomeni: Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
Francesco Del Sole: I Clinica Medica, Atherothrombosis Centre, Department of Internal Medicine and Medical Specialties of Sapienza University of Rome, Rome, Italy
Angela Sciacqua: Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy
Francesco Perticone: Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy
Rossella Marcucci: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Elisa Grifoni: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Pasquale Pignatelli: I Clinica Medica, Atherothrombosis Centre, Department of Internal Medicine and Medical Specialties of Sapienza University of Rome, Rome, Italy
Francesco Violi: I Clinica Medica, Atherothrombosis Centre, Department of Internal Medicine and Medical Specialties of Sapienza University of Rome, Rome, Italy; Correspondence to: I Clinica Medica, Viale del Policlinico 155, Roma 00161, Italy. Fax: +390649970103.

Journal volume & issue: Vol. 17
pp. 830 – 836

Abstract

Read online

This article contains the data showing the different characteristics of atrial fibrillation (AF) patients treated with vitamin K (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs) screened for the presence of liver fibrosis (LF) and followed to record the occurrence of bleeding and cardiovascular events (CVEs). A detailed description of major and minor bleedings is provided according to anticoagulant treatment (VKAs vs. NOACs) and to the presence of LF.Data here reported also show a higher incidence rate of CVEs in VKA-treated patients, but not in those on NOACs. The data are supplemental to our original research article titled “Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonists oral anticoagulants” (Pastori et al., 2018) [1].

Published in Data in Brief

ISSN: 2352-3409 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Medicine (General): Computer applications to medicine. Medical informatics; Science: Science (General)
Website: http://www.journals.elsevier.com/data-in-brief/

About the journal